by John-Michael Dumais, Childrens Health Defense:
A Japanese peer-reviewed study found statistically significant increases in cancer mortality, especially after the third COVID-19 mRNA vaccine dose. John Campbell, Ph.D., analyzed the study on his podcast. During a separate episode, Campbell discussed the study with Angus Dalgleish, a professor of oncology at St. George’s, University of London.
A Japanese peer-reviewed study found statistically significant increases in cancer mortality, especially after the third COVID-19 mRNA vaccine dose, according to John Campbell, Ph.D., a prominent healthcare commentator.
TRUTH LIVES on at https://sgtreport.tv/
In an April 13 podcast, Campbell discussed the study published April 8 in the journal Cureus. The study analyzed official Japanese government statistics to compare age-adjusted cancer mortality rates during the COVID-19 pandemic (2020-2022) with pre-pandemic rates.
Campbell also discussed the findings with oncologist Angus Dalgleish in a podcast that aired today.
Campbell first showed the increases in mortality from all causes in Japan from 2021 through the present. The study indicated a 2.1% mortality increase in 2021 and a 9.6% increase In 2022.
Regarding cancers, the researchers found no significant excess mortality in 2020, but a 1.1% increase in 2021 after the rollout of the first and second vaccine doses, and a 2.1% increase in 2022, after two-thirds of the population had received a third dose of the mRNA COVID-19 vaccines.
Mortality for some cancers increased by as much as 9.7%, according to the study.
The data showed significant increases in mortality from the following cancers:
- Ovarian cancer: increases of 2.5% in 2020, 7.6% in 2021 and 9.7% in 2022.
- Leukemia: a decrease of 0.2% in 2020 and increases of 1.7% in 2021 and 8.0% in 2022.
- Prostate cancer: increases of 1.2% in 2020, 5.3% in 2021 and 5.9% in 2022.
- Oral and pharyngeal cancers: a decrease of 0.6% in 2020 and increases of 1.3% in 2021 and 5.5% in 2022
- Skin cancer: increases of 0.6% in 2020, 0.1% in 2021 and 3.2% in 2022.
- Uterine cancer: decreases of 1.1% in 2020 and 1.3% in 2021, and a 2.5% increase in 2022
“So again we see this strong temporal correlation between quite significantly increased … rates of ovarian cancer with the vaccine rollouts here,” Campbell said, calling each additional correlation “another ‘weird coincidence.’”
“All cancer deaths are statistically significant, Campbell said. “Excess [deaths] emerged in 2021 and increased further in 2022. In addition, significant excess mortality was observed after August 2021, whereas mass vaccination of the general population began around April 2021.”
Campbell noted that while the study did not measure new cases and some types of cancer take years to develop, the findings suggest the vaccines may be accelerating cancer deaths in patients with preexisting tumors.
Read More @ ChildrensHealthDefense.org
